Comparison of Different Risk Scores for Prediction of In-Hospital Mortality in STEMI Patients Treated with PPCI

Table 1

Baseline characteristics, vital signs, and laboratory data.

Variables	All patients (n = 1346)	Survivor (n = 1274)	Nonsurvivors (n = 72)	value
Age (years)	60.5 ± 12.7	60.1 ± 12.5	68.3 ± 13.4	<0.001
Male gender	1134 (84.2)	1086 (85.2)	48 (66.7)	<0.001
Body mass index (kg/m^2)	25.7 ± 4.0	25.7 ± 3.9	26.2 ± 4.8	0.371
Diabetes mellitus	535 (39.7)	493 (38.7)	42 (58.3)	0.001
Hypertension	889 (66.0)	842 (66.1)	47 (65.3)	0.899
Dyslipidemia	1034 (76.8)	983 (77.2)	51 (70.8)	0.250
Current smoking	760 (56.5)	730 (57.3)	30 (41.7)	0.01
Previous myocardial infarction	119 (8.8)	107 (8.4)	12 (16.7)	0.029
Systolic blood pressure^a	138 ± 35	140 ± 34	115 ± 40	<0.001
Heart rate^a	80 ± 21	79 ± 21	92 ± 30	<0.001
Anterior ST elevation	694 (51.6)	660 (51.8)	34 (47.2)	0.469
White blood cell count (k/mm^3)^a	10.9 (8.8–13.7)	10.8 (8.7–13.6)	12.0 (10.2–14.5)	0.042
Hemoglobin (g/dL)^a	14.5 (13.2–15.6)	14.6 (13.3–15.7)	12.9 (10.8–14.5)	<0.001
Hematocrit (%)	42.9 (39.4–45.9)	43.1 (39.6–46.0)	38.7 (33.0–42.8))	<0.001
Platelet count (k/mm^3)^a	219 (184–259)	219 (185–259)	216 (176–275)	0.746
Sugar (mg/dL)^a	159 (131–221)	157 (130–215)	239 (161–348)	<0.001
Creatinine (mg/dL)^a	1.1 (0.9–1.4)	1.1 (0.9–1.3)	1.6 (1.2–2.8)	<0.001
AST (U/L)^a	33 (25–51)	32 (25–48)	73 (41–211)	<0.001
Troponin-I (ng/mL)^a	0.13 (0.03–0.90)	0.12 (0.03–0.79)	0.81 (0.16–9.82)	<0.001
Killip class II-IV^a	517 (38.4)	453 (35.6)	64 (88.9)	<0.001

Data are expressed as mean ± SD or n (%) or median (25th—75th percentile). ^a: All the data were measured upon presentation. .